Cheers to the Rare Moms on Mother’s Day

One year ago - Mother’s Day 2020, I was two and a half months away from meeting my third and final baby girl. 2020 was a tough year for everyone with the COVID pandemic and living our new normal, but it was about to hit a peak for me when I got news just a month later I would have never fathomed. Read a message from Valarie, baby Delila's mom


“How do you know you have IgA nephropathy?” asked Gisela’s nephrologist skeptically. Gisela was 30 years old, talking to a nephrologist for the first time in a decade. Read and watch her story.
RARE-X logo

Travere Therapeutics Reports First Quarter 2021 Financial Results

SAN DIEGO, May 06, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its first quarter 2021 financial results and provided a corporate update.

Read the full press release >

Rare Disease Diversity Coalition Publishes Roadmap to Achieving Health Equity in Rare Disease

On February 26, 2021, Travere Therapeutics was honored to have Linda Goler Blount, president of the Black Women’s Health Imperative (BWHI), present a keynote address at our Rare Disease Day program. The opportunity for Travere team members to hear Linda speak came on the heels of the first meeting of the Rare Disease Diversity Coalition, which is led by BWHI. Read more>


Valarie describes her family's journey with baby Delila who has Alagille syndrome.
PharmaVoice 100 logo

Travere President and Chief Executive Officer Eric Dube Featured in PharmaVOICE Trend Tracking

April 1, 2020 — The April edition of PharmaVOICE magazine features our CEO Eric Dube, Ph.D., along with other members of the PharmaVOICE 100 leadership community on their top priorities for the remainder of 2021 and the leadership skills that helped guide them through the pandemic. View the digital edition >


A tale of racial bias that delayed a diagnosis


Author, composer and life-long learner, Matthew lives with peroxisome biogenesis disorder-Zellweger spectrum disorder (PBD-ZSD).


Hear from Christopher as he describes his journey with focal segmental glomerulosclerosis (FSGS), from diagnosis and day-to-day with this rare kidney disease, to his work with NephCure Kidney International.


At the 2019 ERA-EDTA Congress in Budapest, the company hosted a panel discussion led by people living with rare glomerular disease. Lindsay, a 17-year-old scholar, athlete and musician, shared about her journey with focal segmental glomerulosclerosis (FSGS).